Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux☆
Introduction
ATP-binding cassette (ABC) proteins comprise a large super family of transmembrane transporters that utilize ATP hydrolysis to translocate their substrates across biological membranes. Members of ABC proteins such as drug resistance proteins, P-glycoprotein (P-gp; MDR1) (Dey et al., 2003) and multidrug resistance associated proteins (MRPs) (Merino et al., 2004) are believed to be major barriers to drug delivery. MRPs can confer drug resistance and cause reduced accumulation of therapeutic agents. A reduction in intracellular drug concentrations was found to correlate with the expression of P-gp encoded by multidrug resistance (MDR1) gene and a transmembrane phosphoglycoprotein (MRP) (Bredel et al., 2004, Sawicka et al., 2004). Also, collective role of P-gp and MRPs in efflux of drug molecules has been reported (Xiao et al., 2005). Human cornea has been shown to express P-gp, which serves as a drug efflux pump (Dey et al., 2003, Dey et al., 2004). Erythromycin (Gaynor et al., 2005), cyclosporine-A (Hesselink et al., 2005), quinolones (ciprofloxacin, grepafloxacin) (Naruhashi et al., 2002, Seral et al., 2003, Michot et al., 2004), steroids, sulfated steroids, estradiol 17-beta-d-glucuronide (Chen et al., 2005, Chu et al., 2004, Zelcer et al., 2003) are widely employed in ocular therapy. However, these drugs are known to be good substrates for MRP. ABCC2 (a member of MRP family) is expressed on the bile canalicular membrane of hepatocytes, as well as on the brush border membrane of renal and intestinal epithelial cells. ABCC2 excretes structurally diverse organic anions including reduced glutathione, glutathione conjugates, bilirubin glucuronides, sulfated and glucuronidated bile salts and nonconjugated organic anions into bile (Suzuki and Sugiyama, 1998, Keppler and Konig, 2000), which accounts for most of the bile salt-independent bile flow (Lauterburg et al., 1984). Roelofsen et al. (1991) were the first to report the efflux of ABCC2 substrates from isolated rat hepatocytes. ABCC2 belongs to subfamily C of the ABC super family and this protein confers resistance to a wide array of chemotherapeutic agents. Role of P-gp as a barrier to corneal delivery of drugs has been reported earlier (Kawazu et al., 1999, Dey et al., 2004).
Therefore, the main objective of this study is to determine if human cornea expresses a homologue of MRP, ABCC2 that is known to express on the apical side of cell membrane and to examine the role in drug efflux. In vitro uptake experiments were performed with [3H]-cyclosporine-A, [14C]-erythromycin and specific MRP inhibitor (MK-571) employing human corneal epithelial cells (SV40-HCEC), rabbit primary corneal epithelial cells (rPCEC), and MRP-transfected Madin–Darby canine kidney cells (MDCKII-MRP2). Transport experiments were performed with SV40-HCEC and freshly excised rabbit cornea. Also, RT-PCR immunoprecipitation followed by Western blot analysis were applied to confirm the presence of ABCC2 in corneal epithelium.
Section snippets
Materials and methods
MK-571, a specific inhibitor for MRP family and which does not interact with P-gp (Stephens et al., 2002, Walter et al., 2003, Park and Sinko, 2005) was obtained from Biomol International L.P. (PA, USA). [14C]-erythromycin (specific activity 48.8 mCi/mmol), a proven substrate for MRP (Terashi et al., 2000) was purchased from Perkin-Elmer Life and Analytical Sciences (Boston, MA). [3H]-cyclosporine-A (specific activity: 8 Ci/mol), also a known substrate for MRP (Qadir et al., 2005), [3H]-mannitol
Transfected human corneal epithelial cells
SV40-immortalized human corneal epithelial cell line was obtained as a gift from Araki-Sasaki et al. (1995). Mycoplasma-free SV40-HCEC were grown at 37 °C, humidified 5% CO2/95% air atmosphere in a culture medium containing 50% of Dulbecco's modified Eagle's medium (DMEM) and 50% of Ham's nutrient mixture F-12 (from Gibco, Paisley, UK) supplemented with 15% (v/v) fetal bovine serum (FBS, from Gibco), antibiotic, antimycotic solution (penicillin 100 U/ml, streptomycin 100 μg/ml and amphotericin B 25
Uptake experiments
Uptake studies were conducted according to standard protocols, with minor modifications (Dey et al., 2003). Briefly, 10–12 days after seeding, the medium was aspirated, and cells were rinsed with DPBS (composition: 130 mM NaCl, 7.5 mM Na2HPO4, 1.5 mM KH2PO4, 0.5 mM MgSO4, 1 mM CaCl2, 0.03 mM KCl, and 5 mM glucose and pH 7.4) at 37 °C and then equilibrated in 1 ml of DPBS for 30 min at 37 °C for control and inhibition experiments. IC50 of MK-571 was found to be about ∼110 μM in rPCEC (Karla et al., 2006)
Permeability measurements
Steady-state fluxes were determined from the slope of the cumulative amount of drug transported versus time graph and expressed per unit of cross-sectional surface area of the membrane as described by Eq. (1). The cumulative amount of drug transported is the total amount of drug present in the receiver chamber after a defined time interval.
M is the cumulative amount of drug transported and A is the cross-sectional surface area exposed to permeate. Permeability's of SV40-HCEC
Uptake of [3H]-cyclosporine-A and [14C]-erythromycin in cell culture models
Dose dependant inhibition of ABCC2 was noticed with increased concentrations of MK-571 in both SV40-HCEC and rPCEC. IC50 value obtained for MK-571 in SV40-HCEC was ∼75 μM (Fig. 1) and rPCEC was ∼110 μM (Fig. 2), respectively. Hence concentrations of ∼75 and ∼100 μM were employed for further studies. In MDCKII-MRP2 cells uptake of both [3H]-cyclosporine-A was elevated by ∼1.5-fold (155.51 ± 19.50)% over control (100 ± 10.57)% and uptake of [14C]-erythromycin was elevated by ∼2-fold (195.16 ± 22.99)%,
Discussion
Topical delivery into the cul-de-sac is, by far, the most common route of ocular drug administration. Absorption from this site may involve corneal and/or noncorneal pathways. The noncorneal route involves transport of the drug across the sclera and the conjunctiva into the deeper intraocular tissues. This route of drug absorption results in poor ocular bioavailability. As molecules reach beyond the corneal–scleral junction, absorption by the local capillary beds may result in drug dumping into
Acknowledgements
We would like to thank Dr. Claudio Tiribelli, MD PhD, Director Centro Studi Fegato (Liver Research Center) (Trieste, Italy) for his help with culturing the MDCKII-MRP2 cell line. We would like to thank Dr. Allison McDermott, associate professor, University of Houston (College of optometry) for her help with culturing of SV40-HCEC. We would like to thank Budda Balasubrahmanyam, graduate research fellow, UMKC-School of pharmacy for his excellent contribution in RT-PCR studies.
Reference (36)
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
Anal. Biochem.
(1976)- et al.
Genomics-based hypothesis generation: a novel approach to unraveling drug resistance in brain tumors
Lancet Oncol.
(2004) - et al.
Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2
Am. J. Transplant.
(2005) - et al.
Cloning of an amino acid transporter with functional characteristics and tissue expression pattern identical to that of system A
J. Biol. Chem.
(2000) - et al.
An SV40-immortalized human corneal epithelial cell line and its characterization
Invest. Ophthalmol. Vis. Sci.
(1995) - et al.
Comparison of the effects of continuous and intermittent systemic administration on the penetration of gentamicin into infected rabbit eyes
J. Infect. Dis.
(1983) - et al.
Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998)
Antimicrob. Agents Chemother.
(2000) - et al.
Transport of bile acids, sulfated steroids, estradiol 17-beta-d-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11)
Mol. Pharmacol.
(2005) - et al.
Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3
J. Pharmacol. Exp. Ther.
(2004) - et al.
Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis
Antimicrob. Agents Chemother.
(1993)
Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption
J. Pharmacol. Exp. Ther.
Molecular evidence and functional expression of P-glycoprotein (MDR1) in human and rabbit cornea and corneal epithelial cell lines
Invest. Ophthalmol. Vis. Sci.
Topical ocular antibiotics induce bacterial resistance at extraocular sites
Br. J. Ophthalmol.
Multidrug resistance-associated protein-1 functional activity in Calu-3 cells
J. Pharmacol. Exp. Ther.
Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers
Pharm. Res.
Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving Peptide transporter-mediated influx across rabbit cornea
J. Ocul. Pharmacol. Ther.
Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin
Invest. Ophthalmol. Vis. Sci.
Cited by (52)
Cell-based in vitro models for ocular permeability studies
2016, Concepts and Models for Drug Permeability Studies: Cell and Tissue based In Vitro Culture ModelsProdrug approach to improve absorption of prednisolone
2015, International Journal of PharmaceuticsCitation Excerpt :Despite being highly patient compliant, topical administration faces numerous challenges such as rapid tear turnover, drainage to systemic circulation and non-specific absorption in other ocular tissues (Hariharan et al., 2009a). In addition, corneal epithelium expresses efflux proteins such as P-gp (Dey et al., 2003; Verstraelen and Reichl, 2013) and multidrug resistance associated proteins (MRPs) (Karla et al., 2007a; Karla et al., 2007b; Karla et al., 2009; Verstraelen and Reichl, 2014). These drug efflux pumps play an active role in exporting drug molecules from cornea to tear film resulting in poor drug accumulation in anterior ocular tissues (Dey et al., 2004; Hariharan et al., 2009a,b).
A critical assessment of in vitro tissue models for ADME and drug delivery
2014, Journal of Controlled ReleaseCitation Excerpt :Commercially available human primary corneal epithelial cells (e.g. ATCC, ScienCell) are not much used in permeability studies. The TEER of rabbit primary corneal epithelial cells grown on membrane inserts has been variable ranging from 140 to 250 Ω·cm2 [49–52] to ~ 5000 Ω·cm2 [54], while differentiated human primary corneal epithelial cells showed TEER of less than 100 Ω·cm2 [55]. The culture conditions may influence properties of primary cells such as the expression of drug transporters in case of commercial human corneal epithelial primary cells (HCEpiC).
Biology of ocular transporters: Efflux and influx transporters in the eye
2013, Ocular Transporters and Receptors: Their Role in Drug DeliveryCharacterization of ocular transporters
2013, Ocular Transporters and Receptors: Their Role in Drug DeliveryTransporters and receptors in the anterior segment of the eye
2013, Ocular Transporters and Receptors: Their Role in Drug Delivery
- ☆
This work is supported by NIH Grants R01 EY09171-12 and R01 EY10659-10. Part of this work is presented in a preliminary format at Association of Pharmaceutical Scientists (AAPS) (2005), Nashville, Tennessee, Pharmaceutics Graduate Student Research Meeting (PGSRM) Kansas (2005) and Minnesota (2006).